K
Keystonemab utilizes AI-supported predictive analysis on extensive scientific and clinical data to generate actionable insights for the biopharmaceutical industry. The platform identifies synergistic drug combinations, supports drug repositioning for new indications, and discovers novel druggable targets. This capability enables clients to make informed decisions regarding drug development, portfolio analysis, and addressing rare disease treatments.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Keystonemab utilizes AI-supported predictive analysis on extensive scientific and clinical data to generate actionable insights for the biopharmaceutical industry. The platform identifies synergistic drug combinations, supports drug repositioning for new indications, and discovers novel druggable targets. This capability enables clients to make informed decisions regarding drug development, portfolio analysis, and addressing rare disease treatments.